Papadimitrakopoulou V, et al. IMPOWER132: PFS and safety results with 1L atezolimumab + carboplatin/cisplatin + pemetrexed in stage IV non-squamous NSCLC. IASLC 2018; abstract OA05.07.
Chemopreventie bij non-melanoma skin cancer: acitretine of nicotinamide?
jun 2021 | Dermato-oncologie